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WS2.1 Liposomal clarithromycin effect on bacterial adhesion to
epithelia of cystic ﬁbrosis patients
A. Omri1, M. Halwani2. 1Laurentian University, Chemistry/Biochemistry, Sudbury,
Canada; 2King Abdullah International Medical Research Center (KAIMRC),
Riyadh, Saudi Arabia
Objective: Cystic ﬁbrosis (CF) lungs infected with antibiotic resistant bacteria is
very difﬁcult to treat. Our aim is to improve the effectiveness of existing anti-
pseudomonal drugs through the use of liposomal antibiotic formulations.
Methods: The effect of sub-inhibitory concentrations of liposomal clarithromycin
on P. aeruginosa (PA) adherence to human lung epithelial cell (A549) in culture
and the mechanisms of anti-adherence property of the formulation were investigated
by comparing outer membrane protein proﬁles of antibiotic treated cultures to that
of controls using 2D gel electrophoresis. The release kinetics in CF sputum, the
antibacterial activity against bioﬁlm forms of PA and the mucus penetrating ability
of liposomal clarithromycin in cystic ﬁbrosis sputum were assessed by HPLC,
ﬂuorescence and microbiological assay. The nebulized liposomal clarithromycin was
prepared using a (PARI) nebulizer and the physicochemical properties of nebulized
were analyzed using scanning electron microscopy.
Results: The sub-inhibitory concentrations of liposomal clarithromycin were found
to diminish the ability of PA to bind to human lung epithelial cell (A549). The
liposomal formulation penetrated into deep mucus layers and kept it up longer.
The antibacterial activity liposomal clarithromycin against bioﬁlm forms of PA was
increased by several folds compared to clarithromycin alone.
Conclusion: These liposomal formulation played an important role in preventing
the attachment of PA to cell surfaces and their administration by Inhalation is
achievable. This strategy could prevent PA from causing infections and damaging
the lung in CF patients.
WS2.2 Identiﬁcation of two novel immunogenic Burkholderia cepacia
complex proteins involved in lung cell attachment
R. Dennehy1, C. Mujica2, M. Valvano2, M. Callaghan1, S. McClean1. 1Institute of
Technology Tallaght, Dublin, Ireland; 2Queen’s University Belfast, Belfast, United
Kingdom
Burkholderia cepacia complex (Bcc) infection can result in a fatal necrotising
pneumonia and bacteraemia in a subgroup of CF patients. While several virulence
factors have been identiﬁed, the pathogenesis of Bcc has not been fully elucidated.
We previously identiﬁed immunogenic proteins from B. cenocepacia and B. multivo-
rans using immunoproteomics. Two-dimensional blots of Bcc proteins were probed
with serum from Bcc colonised CF patients. Twelve B. cenocepacia and 14 B. mul-
tivorans immunogenic proteins were identiﬁed using MALDI-Tof MS, of which six
proteins were common to both species. An OmpA family lipoprotein (BCAL3204)
and a hypothetical protein located on a pathogenicity island (BCAS0292), were
chosen to investigate their role in virulence.
Targeted deletion mutants were developed and examined in the Galleria mellonella
virulence model. The virulence of the BCAL3204 mutant was signiﬁcantly reduced
(p< 0.001) in comparison to the wild-type (WT), conﬁrming its pathogenic role. In
contrast, larvae injected with supernatant from this mutant displayed lower survival
compared to the WT supernatant suggesting a structural role for this protein.
Confocal microscopy showed that, in comparison to the WT, the BCAS0292 and
BCAL3204 mutants displayed a three-fold and two-fold reduction in adhesion to
CF epithelial cells, respectively, demonstrating that both proteins may play a role
in host lung cell attachment.
Both proteins have been recombinantly expressed and their characterisation will
provide a clearer understanding of their roles in Bcc pathogenesis, which may
lead to their development as potential vaccine antigens or targets for anti-virulence
therapies.
WS2.3 Multifaceted iron acquisition mechanisms of Burkholderia
cenocepacia
N. Whelan1, M. Thomas2, S. Doyle3, M. Callaghan1. 1Institute of Technology
Tallaght, Dublin, Ireland; 2University of Shefﬁeld, Shefﬁeld, United Kingdom;
3National University of Ireland Maynooth, Co. Kildare, Ireland
The Burkholderia cepacia complex (Bcc) is a group of antibiotic resistant, op-
portunistic pathogens associated with a high mortality rate in cystic ﬁbrosis (CF).
Burkholderia cenocepacia, one of the more clinically relevant members of the Bcc,
produces iron chelating molecules known as siderophores to acquire iron in the host.
This study demonstrated that in iron-depleted cultures (0mM and 1mM) siderophore
production by B. cenocepacia was signiﬁcantly upregulated by 4 h (P< 0.001) with
maximal production by 5 h. At 2mM and 3mM iron, siderophore responses were
signiﬁcantly upregulated by 6 h (P< 0.001) and were maximal by 7 h. We examined
the ability of B. cenocepacia to acquire iron from other sources such as host iron-
binding proteins and xenosiderophores. Ornibactin deﬁcient mutants demonstrated
a 7 fold growth increase with ferritin (P< 0.001) and a 6 fold increase with hemin
(P< 0.001). B. cenocepacia wild type strains showed a 16 and 10 fold increase
in growth in the presence of ferritin and hemin, respectively, indicating that these
mechanisms are siderophore-independent. Lactoferrin and transferrin had no effect
on B. cenocepacia growth. Both wild type and mutant strains of B. cenocepacia
demonstrated signiﬁcantly enhanced growth in the presence of Aspergillus fumigatus
siderophores, triacetylfusarinine C and fusarinine C, demonstrating the potential
for inter-kingdom competition between these pathogens. The multifaceted iron
acquisition strategies employed by B. cenocepacia facilitate colonisation of the
iron-restricted niche of the CF lung and survival in a polymicrobial community and
thus warrant further investigation as potential therapeutic targets.
WS2.4 Pseudomonas aeruginosa capability to colonize the CF lung
may be favored by its remarkable ability to recruit zinc under
conditions of limited metal availability
M. D’Orazio1, M. Cerasi1, M.C. Mastropasqua1, B. Chirullo2, P. Pasquali2,
A. Battistoni1. 1University of Rome Tor Vergata, Biology, Roma, Italy; 2Istituto
Superiore di Sanita`, Roma, Italy
Objectives: Calprotectin (CP) is likely the most abundant protein present in the
sputum from CF patients. Although CP is usually considered just as a marker
of inﬂammation, it is a zinc and manganese sequestering antimicrobial protein,
released by neutrophils at sites of infection to contain microbial proliferation. It
has been recently shown that the ability of several pathogens to withstand the
antimicrobial activity of CP relies on their ability to produce metal transporters
characterized by high afﬁnity for the Zn ion. On this ground, we hypothesize that
the ability P. aeruginosa to colonize the inﬂamed CF lung must be supported by
effective strategies to counteract CP-induced metal starvation. Therefore, in the
light of recent studies showing that it is possible to pharmacologically target Zn
homeostasis in pathogenic microorganisms, we have undertaken a characterization
of the Zn import apparatus of P. aeruginosa and of its contribution to bacterial
ability to colonize the CF lung.
Methods: We have generated strains lacking the two known ATP-dependent Zn
importers ZnuABC and HmtA and carried out experiments to evaluate their
contribution to bacterial growth in Zn-limiting conditions and in infected mice.
Results: Although the mutants strains lacking znuABC show some defects in
motility and alginate production, the mutant strains display modest growth defects in
Zn-limited environments, elevated intracellular Zn content and a limited reduction
of virulence in mice.
Conclusions: P. aeruginosa is equipped with redundant mechanisms for the acqui-
sition of Zn which may contribute to colonization of the CF lung by favoring the
evasion of the antimicrobial action of CP.
